{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:50:19Z","timestamp":1779144619051,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2470,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,10,2]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Nutrient malabsorption is a negative prognostic factor in acquired immunodeficiency syndrome and recent studies have shown that pancreatic insufficiency is a codetermining factor of malabsorption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims:<\/jats:title><jats:p>To evaluate the effectiveness of open\u2010label oral pancreatic enzyme supplementation therapy in acquired immunodeficiency syndrome patients with fat malabsorption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods:<\/jats:title><jats:p>Twenty\u2010four consecutive patients with human immunodeficiency virus infection and fat malabsorption were recruited (11 males, 13 females; median age, 9.1\u2003years). Faecal fat loss was evaluated by steatocrit assay at entry to the study (T\u20100), after 2\u2003weeks (T\u20101) without pancreatic enzyme treatment and after a further 2\u2003weeks (T\u20102) of treatment with pancreatic extracts (Creon 10\u2003000 at a dose of 1000\u2003units of lipase per gram of ingested dietary fat). Faecal elastase\u20101 and chymotrypsin were assayed at entry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Six patients (25%) had abnormally low elastase\u20101 and\/or chymotrypsin faecal concentration. In all patients, steatocrit values were elevated at both T\u20100 and T\u20101. Five patients proved intolerant to pancreatic enzyme treatment because of the onset of abdominal pain, and therapy was discontinued. In the 19 patients who concluded the study, steatocrit values during pancreatic enzyme treatment (T\u20102) were significantly lower than at entry (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). At T\u20102, in eight of 19 patients, steatocrit values were within the normal limit and the frequency of cases cured or improved on pancreatic enzyme therapy (at T\u20102) was significantly higher than that observed during the previous study period without enzyme treatment (T\u20101) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). A positive significant correlation was found between steatocrit values at entry and the Centers for Disease Control class (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0005); also, the decrease in steatocrit values during pancreatic enzyme therapy (difference between steatocrit value at T\u20102 and steatocrit value at T\u20100) positively correlated with the Centers for Disease Control class (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>This pilot, open\u2010label study showed that pancreatic enzyme supplementation therapy is highly effective in reducing faecal fat loss in human immunodeficiency virus\u2010infected patients with nutrient malabsorption. Further double\u2010blind studies must be undertaken to verify these results and, if they are confirmed, pancreatic enzymes can be added to our weapons in the fight against human immunodeficiency virus\u2010associated nutrient malabsorption.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.01070.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:43:10Z","timestamp":1047354190000},"page":"1619-1625","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV\u2010infected patients"],"prefix":"10.1111","volume":"15","author":[{"given":"A.","family":"Carroccio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Verghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Berni Canani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Montalto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Notarbartolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_9_2_2","unstructured":"UNAIDS.AIDS epidemic update. December 15\u2013171998.http:\/\/www.unaids.org"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804303381808"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01034-3"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199311000-00005"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82147-X"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90781-F"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.4.558"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025958"},{"key":"e_1_2_9_10_2","first-page":"1","article-title":"1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"Mortality, Morbidity, Weekly Report"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02220441"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199007000-00011"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199204000-00006"},{"key":"e_1_2_9_14_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/clinchem\/42.2.222","article-title":"Immunoreactive elastase I: clinical evaluation of a new non\u2010invasive test of pancreatic function","volume":"42","author":"Stein J","year":"1996","journal-title":"Clin Chem"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178674"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(93)90047-V"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001574-199104000-00015"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91052-5"},{"key":"e_1_2_9_19_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00002030-200009080-00001","article-title":"Involvement of the pancreas in AIDS: a prospective study of 109 post\u2010mortems","volume":"14","author":"Chehter EZ","year":"2000","journal-title":"AIDS"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655298750027056"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199788"},{"key":"e_1_2_9_22_2","first-page":"307","article-title":"Ritonavir combination therapy restores intestinal function in children with advanced HIV disease","volume":"21","author":"Berni Canani R","year":"1999","journal-title":"J AIDS"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01070.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01070.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.01070.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:04:33Z","timestamp":1697537073000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.01070.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,2]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,10,2]]}},"alternative-id":["10.1046\/j.1365-2036.2001.01070.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01070.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10,2]]}}}